Abstract
Ischemic stroke is a leading cause of mortality and morbidity worldwide, and atherosclerosis is one of the major risk factors for this neurologic deficit. Recent studies have revealed the important role of CD137 in human atherosclerosis. Here, we analyzed the association of CD137 single nucleotide polymorphisms (SNPs) with ischemic stroke. We assessed three SNPs (rs161827, rs161818, and rs161810) of the CD137 gene and their association with ischemic stroke in a northern Chinese Han population. A total of 496 ischemic stroke patients and 486 gender-matched control subjects were genotyped. We classified these patients according to complications with diabetes and hypertension and also by ischemic stroke subtypes. Allele, genotype, and haplotype association studies were tested in all patients and subgroups. We used multivariable logistic regression analysis combined with 10,000 permutations to analyze the association of CD137 polymorphisms with ischemic stroke. After adjusting for relevant factors, rs161827 was significantly different between patients with and without diabetes and the control group (p = 0.0001, p = 0.014, and p = 0.0001, respectively). In addition, rs161818 and rs161810 differed significantly between patients without diabetes and the control subjects (p = 0.0001 and p = 0.004, respectively). rs161827, rs161818, and rs161810 were all statistically significant among the combination stroke subgroup compared with the controls. These results indicate that the CD137 gene is associated with risk of ischemic stroke in the northern Han Chinese. Moreover, CD137 gene polymorphism may be one mediating factor between diabetes and ischemic stroke.
Similar content being viewed by others
References
Adams, H. P., Jr., Bendixen, B. H., Kappelle, L. J., Biller, J., Love, B. B., Gordon, D. L., et al. (1993). Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke, 24(1), 35–41.
Amarenco, P., Cohen, A., Tzourio, C., Bertrand, B., Hommel, M., Besson, G., et al. (1994). Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. New England Journal of Medicine, 331(22), 1474–1479. doi:10.1056/nejm199412013312202.
Arch, R. H., & Thompson, C. B. (1998). 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor kappaB. Molecular and Cellular Biology, 18(1), 558–565.
Croft, M. (2003). Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nature Reviews Immunology, 3(8), 609–620. doi:10.1038/nri1148.
Dang, M., Wang, Z., Zhang, R., Li, X., Peng, Y., Han, X., et al. (2015). KALRN rare and common variants and susceptibility to ischemic stroke in Chinese Han population. Neuromolecular Medicine, 17(3), 241–250. doi:10.1007/s12017-015-8352-z.
Feigin, V. L., Lawes, C. M., Bennett, D. A., & Anderson, C. S. (2003). Stroke epidemiology: A review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurology, 2(1), 43–53.
Guilherme, A., Virbasius, J. V., Puri, V., & Czech, M. P. (2008). Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nature Reviews Molecular Cell Biology, 9(5), 367–377. doi:10.1038/nrm2391.
Haga, T., Suzuki, J., Kosuge, H., Ogawa, M., Saiki, H., Haraguchi, G., et al. (2009). Attenuation of experimental autoimmune myocarditis by blocking T cell activation through 4-1BB pathway. Journal of Molecular and Cellular Cardiology, 46(5), 719–727. doi:10.1016/j.yjmcc.2009.02.003.
Hansson, G. K. (2005). Inflammation, atherosclerosis, and coronary artery disease. New England Journal of Medicine, 352(16), 1685–1695. doi:10.1056/NEJMra043430.
Hassan, A., & Markus, H. S. (2000). Genetics and ischaemic stroke. Brain, 123(Pt 9), 1784–1812.
Irie, J., Wu, Y., Kachapati, K., Mittler, R. S., & Ridgway, W. M. (2007). Modulating protective and pathogenic CD4+subsets via CD137 in type 1 diabetes. Diabetes, 56(1), 186–196. doi:10.2337/db06-0793.
Jeon, H. J., Choi, J. H., Jung, I. H., Park, J. G., Lee, M. R., Lee, M. N., et al. (2010). CD137 (4-1BB) deficiency reduces atherosclerosis in hyperlipidemic mice. Circulation, 121(9), 1124–1133. doi:10.1161/circulationaha.109.882704.
Joutel, A., Corpechot, C., Ducros, A., Vahedi, K., Chabriat, H., Mouton, P., et al. (1996). Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature, 383(6602), 707–710. doi:10.1038/383707a0.
Jung, I. H., Choi, J. H., Jin, J., Jeong, S. J., Jeon, S., Lim, C., et al. (2014). CD137-inducing factors from T cells and macrophages accelerate the destabilization of atherosclerotic plaques in hyperlipidemic mice. Faseb Journal, 28(11), 4779–4791. doi:10.1096/fj.14-253732.
Kim, C. S., Kim, J. G., Lee, B. J., Choi, M. S., Choi, H. S., Kawada, T., et al. (2011). Deficiency for costimulatory receptor 4-1BB protects against obesity-induced inflammation and metabolic disorders. Diabetes, 60(12), 3159–3168. doi:10.2337/db10-1805.
Klingenberg, R., Gerdes, N., Badeau, R. M., Gistera, A., Strodthoff, D., Ketelhuth, D. F., et al. (2013). Depletion of FOXP3+regulatory T cells promotes hypercholesterolemia and atherosclerosis. Journal of Clinical Investigation, 123(3), 1323–1334. doi:10.1172/jci63891.
Kwon, B. (2009). CD137–CD137 Ligand Interactions in Inflammation. Immune Network, 9(3), 84–89. doi:10.4110/in.2009.9.3.84.
Legein, B., Temmerman, L., Biessen, E. A., & Lutgens, E. (2013). Inflammation and immune system interactions in atherosclerosis. Cellular and Molecular Life Sciences, 70(20), 3847–3869. doi:10.1007/s00018-013-1289-1.
Libby, P., Ridker, P. M., & Hansson, G. K. (2011). Progress and challenges in translating the biology of atherosclerosis. Nature, 473(7347), 317–325. doi:10.1038/nature10146.
Lo, J. C., Wang, Y., Tumanov, A. V., Bamji, M., Yao, Z., Reardon, C. A., et al. (2007). Lymphotoxin beta receptor-dependent control of lipid homeostasis. Science, 316(5822), 285–288. doi:10.1126/science.1137221.
Olofsson, P. S., Soderstrom, L. A., Wagsater, D., Sheikine, Y., Ocaya, P., Lang, F., et al. (2008). CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice. Circulation, 117(10), 1292–1301. doi:10.1161/circulationaha.107.699173.
Ria, M., Eriksson, P., Boquist, S., Ericsson, C. G., Hamsten, A., & Lagercrantz, J. (2006). Human genetic evidence that OX40 is implicated in myocardial infarction. Biochemical and Biophysical Research Communications, 339(3), 1001–1006. doi:10.1016/j.bbrc.2005.11.092.
Sabbagh, L., Pulle, G., Liu, Y., Tsitsikov, E. N., & Watts, T. H. (2008). ERK-dependent Bim modulation downstream of the 4-1BB-TRAF1 signaling axis is a critical mediator of CD8 T cell survival in vivo. Journal of Immunology, 180(12), 8093–8101.
Saoulli, K., Lee, S. Y., Cannons, J. L., Yeh, W. C., Santana, A., Goldstein, M. D., et al. (1998). CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand. Journal of Experimental Medicine, 187(11), 1849–1862.
Schonbeck, U., & Libby, P. (2001). CD40 signaling and plaque instability. Circulation Research, 89(12), 1092–1103.
Seo, S. K., Choi, J. H., Kim, Y. H., Kang, W. J., Park, H. Y., Suh, J. H., et al. (2004). 4-1BB-mediated immunotherapy of rheumatoid arthritis. Nature Medicine, 10(10), 1088–1094. doi:10.1038/nm1107.
Shao, Z., & Schwarz, H. (2011). CD137 ligand, a member of the tumor necrosis factor family, regulates immune responses via reverse signal transduction. Journal of Leukocyte Biology, 89(1), 21–29. doi:10.1189/jlb.0510315.
Shuford, W. W., Klussman, K., Tritchler, D. D., Loo, D. T., Chalupny, J., Siadak, A. W., et al. (1997). 4-1BB costimulatory signals preferentially induce CD8+T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. Journal of Experimental Medicine, 186(1), 47–55.
Sica, G., & Chen, L. (2000). Modulation of the immune response through 4-1BB. Advances in Experimental Medicine and Biology, 465, 355–362. doi:10.1007/0-306-46817-4_30.
Soderstrom, L. A., Gertow, K., Folkersen, L., Sabater-Lleal, M., Sundman, E., Sheikine, Y., et al. (2014). Human genetic evidence for involvement of CD137 in atherosclerosis. Molecular Medicine, 20, 456–465. doi:10.2119/molmed.2014.00004.
Steinberg, H. O., Paradisi, G., Cronin, J., Crowde, K., Hempfling, A., Hook, G., et al. (2000). Type II diabetes abrogates sex differences in endothelial function in premenopausal women. Circulation, 101(17), 2040–2046.
Sytwu, H. K., Lin, W. D., Roffler, S. R., Hung, J. T., Sung, H. S., Wang, C. H., et al. (2003). Anti-4-1BB-based immunotherapy for autoimmune diabetes: Lessons from a transgenic non-obese diabetic (NOD) model. Journal of Autoimmunity, 21(3), 247–254.
Takahashi, C., Mittler, R. S., & Vella, A. T. (1999). Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal. Journal of Immunology, 162(9), 5037–5040.
Tournier-Lasserve, E. (2002). New players in the genetics of stroke. New England Journal of Medicine, 347(21), 1711–1712. doi:10.1056/NEJMcibr022035.
Vinay, D. S., & Kwon, B. S. (1999). Relative abilities of 4-1BB (CD137) and CD28 to co-stimulate the response of cytokine deflected Th1 and Th2 cells. Immunobiology, 200(2), 246–263.
Watts, T. H. (2005). TNF/TNFR family members in costimulation of T cell responses. Annual Review of Immunology, 23, 23–68. doi:10.1146/annurev.immunol.23.021704.115839.
Zhang, R., Li, X., Liu, N., Guo, X., Liu, W., Ning, C., et al. (2013). An association study on renalase polymorphisms and ischemic stroke in a Chinese population. Neuromolecular Med, 15(2), 396–404. doi:10.1007/s12017-013-8227-0.
Zhang, L. F., Yang, J., Hong, Z., Yuan, G. G., Zhou, B. F., Zhao, L. C., et al. (2003). Proportion of different subtypes of stroke in China. Stroke, 34(9), 2091–2096. doi:10.1161/01.str.0000087149.42294.8c.
Acknowledgements
This study was supported by the National Natural Science Foundation of China (No. 81671689).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declared no conflict of interest.
Informed Consent
All subjects agreed with the ethics examination and signed informed consent.
Ethical Approval
The research was approved by the ethics committee of 2nd Affiliated Hospital of Harbin Medical University.
Rights and permissions
About this article
Cite this article
Zhang, S., Li, Z., Zhang, R. et al. Novel CD137 Gene Polymorphisms and Susceptibility to Ischemic Stroke in the Northern Chinese Han Population. Neuromol Med 19, 413–422 (2017). https://doi.org/10.1007/s12017-017-8457-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12017-017-8457-7